白日兰, 崔久嵬. 肿瘤异质性-精准临床诊治的挑战[J]. 中国肿瘤临床, 2020, 47(21): 1081-1087. DOI: 10.3969/j.issn.1000-8179.2020.21.341
引用本文: 白日兰, 崔久嵬. 肿瘤异质性-精准临床诊治的挑战[J]. 中国肿瘤临床, 2020, 47(21): 1081-1087. DOI: 10.3969/j.issn.1000-8179.2020.21.341
BAI Rilan, Cui Jiuwei. Tumor heterogeneity: the great challenge in precision clinical diagnosis and treatment[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 47(21): 1081-1087. DOI: 10.3969/j.issn.1000-8179.2020.21.341
Citation: BAI Rilan, Cui Jiuwei. Tumor heterogeneity: the great challenge in precision clinical diagnosis and treatment[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 47(21): 1081-1087. DOI: 10.3969/j.issn.1000-8179.2020.21.341

肿瘤异质性-精准临床诊治的挑战

Tumor heterogeneity: the great challenge in precision clinical diagnosis and treatment

  • 摘要: 肿瘤异质性是肿瘤演化过程中出现的一个普遍而又至关重要的表现特征,是肿瘤形成及进一步演进的重要支撑点。尽管近几年,肿瘤异质性内在规律和形成机制等方面的研究有诸多新进展,但肿瘤异质性仍是实现临床精准诊治、克服耐药问题的重大挑战。近几年,随着高通量测序和单细胞测序技术的发展和不断完善,对肿瘤单个细胞或全基因组测序已逐步揭示肿瘤异质性的时空变异和分子机制。本篇文章对肿瘤异质性的复杂性、形成机制和对肿瘤演进的影响以及对临床诊治带来的挑战的最新研究进展进行综述。

     

    Abstract: Tumor heterogeneity is a common and important feature in the process of tumor evolution, supporting both tumor formation and further evolution. Although advances have been made in understanding the internal laws and formation mechanisms of tumor heterogeneity, tumor heterogeneity remains a major challenge to achieving an accurate clinical diagnosis, treatment plan, and overcoming drug resistance. With the development and continuous improvement of high-throughput sequencing and single-cell sequencing technology, the spatiotemporal variation and molecular mechanisms of tumor heterogeneity have been increasingly elucidated. Here, we systematically review the latest research progress in the complexity and formation mechanism of tumor heterogeneity, the effect that tumor heterogeneity has on tumor evolution, and its challenges in relation to clinical diagnosis and treatment.

     

/

返回文章
返回